CNTA vs. MBX
CNTA (Centessa Pharmaceuticals Limited) and MBX (MBX Biosciences, Inc) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past year, CNTA returned 180.67% vs 368.17% for MBX. At a 0.24 correlation, their price movements are largely independent.
Performance
CNTA vs. MBX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CNTA achieves a 61.94% return, which is significantly lower than MBX's 93.56% return.
CNTA
- 1D
- 0.00%
- 1M
- 1.96%
- 6M
- 80.64%
- YTD
- 61.94%
- 1Y
- 180.67%
- 3Y*
- 80.39%
- 5Y*
- 10.58%
- 10Y*
- —
MBX
- 1D
- -7.09%
- 1M
- 71.92%
- 6M
- 92.83%
- YTD
- 93.56%
- 1Y
- 368.17%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
CNTA vs. MBX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
CNTA Centessa Pharmaceuticals Limited | 61.94% | 49.31% | 10.93% |
MBX MBX Biosciences, Inc | 93.56% | 71.13% | -19.87% |
Correlation
The correlation between CNTA and MBX is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.21 |
Correlation (All Time) Calculated using the full available price history since Sep 13, 2024 | 0.24 |
Fundamentals
CNTA:
-$1.81
MBX:
-$2.22
CNTA:
$15.00M
MBX:
$0.00
CNTA:
$15.00M
MBX:
-$160.00K
CNTA:
-$227.27M
MBX:
-$96.31M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CNTA vs. MBX — Risk / Return Rank
CNTA
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
MBX
CNTA vs. MBX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Centessa Pharmaceuticals Limited (CNTA) and MBX Biosciences, Inc (MBX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CNTA | MBX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.18 | ||
| Sortino ratioReturn per unit of downside risk | +0.92 | ||
| Omega ratioGain probability vs. loss probability | 1.67 | 1.49 | +0.19 |
| Calmar ratioReturn relative to maximum drawdown | 7.69 | 10.52 | -2.83 |
| Martin ratioReturn relative to average drawdown | 21.44 | 20.10 | +1.33 |
Loading charts...
Drawdowns
CNTA vs. MBX - Drawdown Comparison
The maximum CNTA drawdown since its inception was -88.19%, which is greater than MBX's maximum drawdown of -77.71%. Use the drawdown chart below to compare losses from any high point for CNTA and MBX.
Loading charts...
Drawdown Indicators
| CNTA | MBX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -88.19% | -77.71% | -10.48% |
Max Drawdown (1Y)Largest decline over 1 year | -26.38% | -37.60% | +11.22% |
Max Drawdown (3Y)Largest decline over 3 years | -43.72% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -86.89% | — | — |
Current DrawdownCurrent decline from peak | 0.00% | -7.09% | +7.09% |
Average DrawdownAverage peak-to-trough decline | -51.46% | -33.53% | -17.93% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.45% | 19.63% | -10.18% |
Volatility
CNTA vs. MBX - Volatility Comparison
The current volatility for Centessa Pharmaceuticals Limited (CNTA) is 1.20%, while MBX Biosciences, Inc (MBX) has a volatility of 23.05%. This indicates that CNTA experiences smaller price fluctuations and is considered to be less risky than MBX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CNTA | MBX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 1.20% | 23.05% | -21.85% |
Volatility (6M)Calculated over the trailing 6-month period | 42.79% | 58.36% | -15.57% |
Volatility (1Y)Calculated over the trailing 1-year period | 65.38% | 134.74% | -69.36% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 71.64% | 117.59% | -45.95% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 72.01% | 117.59% | -45.58% |
Dividends
CNTA vs. MBX - Dividend Comparison
Neither CNTA nor MBX has paid dividends to shareholders.
Financials
CNTA vs. MBX - Financials Comparison
This section allows you to compare key financial metrics between Centessa Pharmaceuticals Limited and MBX Biosciences, Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
CNTA and MBX have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
MBX has higher volatility (23.05%) compared to CNTA (1.20%). In terms of maximum drawdown, CNTA dropped -88.19% vs MBX's -77.71%.
CNTA currently has the higher Sharpe Ratio (3.12 vs 2.94), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CNTA and MBX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer